Other
Remimazolam Besylate
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Remimazolam Besylate is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
6
clinical trials
Not yet recruiting2 · 33%
Unknown status2 · 33%
Recruiting1 · 17%
Completed1 · 17%
Clinical Trials
Trial Activity
6 trials
Sedative Effect and Safety of Remimazolam Besylate in ARDS Patients
Recruiting·—·Phase 4·NCT05758597·100 enrolled
The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia
Not yet recruiting·—·Phase 1·NCT06717945·320 enrolled
The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction
Completed·SSecond Affiliated Hospital of Wenzhou Medical University·Phase 4·NCT06061159·120 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)